Dementia is a decline in memory and/or intellectual functioning severe enough to interfere with social or occupational functioning. Dementia is not a disease itself, but group of symptoms. It is characterized as a progressive decline in cognitive function due to damage or disease (such as Alzheimer’s) in the brain. Areas particularly affected include: memory, attention, [...]
In the days leading up to Memorial Day, I found myself reflecting on the true meaning of the day. Memorial Day is commemorated differently. To some it is simply the beginning of summer and an opportunity to gather with friends and family around a BBQ , a beach or park. To others it’s a time [...]
Early-onset Alzheimer’s disease is one of 38 degenerative conditions included in the Social Security Administration’s new Compassionate Allowances program. This fast-tracking system is designed to aid younger patients and their families in moving quickly from diagnosis to benefits. Expediting this process aids in reducing stress associated with waiting for the lengthy approval process, and trying [...]
In this Leaders in Elder Care interview, I had the privilege to speak to Dr. Kevin O’Neil. I first met Dr. O’Neil at Brookdale’s Brain Symposium a few months ago at UCLA, where I left quite impressed with the his approach to brain fitness and brain health. Dr. O’Neil combines a deep understanding of both [...]
A fascinating interview appeared in Scientific American this morning. Mind Matters editor Jonah Lehrer interviews P. Murali Doraiswamy, the head of biological psychiatry at Duke University and a Senior Fellow at Duke’s Center for the Study of Aging. He’s also the co-author of The Alzheimer’s Action Plan, a guide for patients and family members struggling [...]
A dear friend of Inside Elder Care, Kim McRae, just shared a wonderful opportunity to learn more about the second leading type of demntia after Alzheimer’s. Betwixt and Intermixed – Dementia With Lewy Bodies Three members of the Lewy Body Dementia Association Scientific Advisory Council (SAC) are participating in an upcoming free webinar on dementia [...]
From Indystar.com: A third set of clinical trials to seek a drug to delay the progression of mild to moderate Alzheimer’s disease is about to get underway, drugmaker Eli Lilly and Co. said today. The Indianapolis company will begin enrolling patients this month in two separate but identical Phase III clinical trials of Solanezumab, an [...]
This morning I went to the gym, just like I’ve done 3-4 times a week for years. I really try to push myself at the end of each workout. My motivation comes from my desire to be healthy, active and have the longevity to spend many, many years with my wife and daughter. But did [...]